Analysis on risk of atrial fibrillation due to ivabradine based on the US FDA Adverse Event Reporting System

Xie Zhenguo, Chen Lin, Yu Kun, Peng Zhe, Gong Hongmei, Liao Yunpeng, Lin Min

PDF(408 KB)
PDF(408 KB)
Adverse Drug Reactions Journal ›› 2021, Vol. 23 ›› Issue (2) : 69-75. DOI: 10.3760/cma.j.cn114015-20200706-00742

Analysis on risk of atrial fibrillation due to ivabradine based on the US FDA Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 23(2): 69-75 https://doi.org/10.3760/cma.j.cn114015-20200706-00742

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(408 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉